- Ceftibuten
Drugbox
IUPAC_name = (6R,7R)-7-( [(Z)-2-(2-amino-1,3-thiazol-4-yl)-5-hydroxy-5-oxopent-2-enoyl] amino) -8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2-ene-2-carboxylic acid
width=250
CAS_number=97519-39-6
ATC_prefix=
ATC_suffix=
ATC_supplemental=
PubChem=5282242
DrugBank=
C=15 | H=14 | N=4 | O=6 | S=2
molecular_weight = 410.427 g.mol-1
bioavailability=
metabolism =
elimination_half-life=
excretion =
pregnancy_category =
legal_status =
routes_of_administration=Ceftibuten is a third-generation
cephalosporin antibiotic . It is an orally-administered agent, with 2 dosage forms, capsule or oral suspension. It is marketed by Shionogi USA under the trade name CedaxClinical use
Indications
Ceftibuten is used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.
Formulations
Ceftibuten is available as capsules containing 400 mg, and a powder for oral suspension containing 90 mg per 5 ml.
ee also
*
Cephalosporin External links
* [http://www.cedax.com Manufacturer's website]
* [http://www.rxlist.com/cgi/generic2/ceftibuten.htm Drug information from RxList]
Wikimedia Foundation. 2010.
